315
Views
11
CrossRef citations to date
0
Altmetric
Review

Asthma outcome measures

, &
Pages 447-453 | Published online: 09 Jan 2014

References

  • National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart Lung and Blood Institute, Bethesda, MD, USA (2007).
  • Reddel H, Taylor R, Bateman E et al. An Official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Repir. Crit. Care Med.180, 59–99 (2009).
  • Tarrant MA, Manfredo MJ, Bayley PB, Hess R. Effects of recall bias and nonresponse bias on self-report estimates of angling participation. North Am. J. Fisheries Management13, 217–222 (1993).
  • McLeod LD, Coon CD, Martin S, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev. Pharmacoeconomics Outcomes Res.11(2), 163–169 (2011).
  • National Asthma Education and Prevention Program Expert Panel Report: 2. Guidelines for the Diagnosis and Management of Asthma, National Heart Lung and Blood Institute, Bethesda, MD, USA (1997).
  • Taylor DR, Bateman ED, Boulet L-P et al. A new perspective on concepts of asthma severity and control. Eur. Respir. J.32, 545–554 (2008).
  • Woolcock A, Rubinfeld AR, Seale JP et al. Thoracic Society of Australia and New Zealand. Asthma management plan. Med. J. Aust.151, 650–653 (1989).
  • National Heart Lung and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur. Respir. J.5, 601–641 (1992).
  • Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med.157, 4–9 (1998).
  • Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol.103, 232–237 (1999).
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J.14, 902–907 (1999).
  • Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest114(4), 998–1007 (1998).
  • Li JTC, O’Connell EJ. Clinical evaluation of asthma. Ann. Allergy Asthma Immunol.76(1), 1–14 (1996).
  • Pinnock H, Fletcher M, Holmes S et al. Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim. Care Respir. J.19(1), 75–83 (2010).
  • Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am. Rev. Respir. Dis.147, 832–838 (1993).
  • Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur. Respir. J.10, 646–651 (1997).
  • Hays RD, Reeve BB. Measurement and modeling of health-related quality of life. In: Epidemiology and Demography in Public Health. Killewo J, Heggenhougen HK, Quah SR (Eds). Elsevier, Oxford, UK, 195–205 (2010).
  • Ford ES, Mannino DM, Redd SC, Moriarty DG, Mokdad AH. Determinants of quality of life among people with asthma: findings from the Behavioral Risk Factor Surveillance System. J. Asthma41, 327–336 (2004).
  • Smith AW, Reeve BB, Bellizzi KM et al. Cancer, comorbidities and health-related quality of life of older adults. Health Care Financ. Rev.29(4), 41–56 (2008).
  • Escorpizo R, Bombardier C, Boonen A et al. Worker productivity outcome measures in arthritis. J. Rheumatol.34(6), 1372–1380 (2007).
  • Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am. J. Manag. Care3(4), 211–217 (2007).
  • Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics22(4), 225–244 (2004).
  • Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics22(3), 165–184 (2004).
  • Lerner DJ, Amick BC III, Rogers WH, Malspeis S, Bungay K. The work limitations questionnaire: a self-administered instrument for assessing on-the-job work disability. Med. Care39(1), 72–85 (2001).
  • Kessler RC, Ames M, Hymel PA et al. Using the WHO health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J. Occup. Environ. Med.46(Suppl. 6), S23–S37 (2004).
  • Kessler RC, Barber C, Beck AL et al. The World Health Organization health and work performance questionnaire (HPQ). J. Occup. Environ. Med.45(2), 156–174 (2003).
  • Schultz AB, Edington DW. Employee health and presenteeism: a systematic review. J. Occup. Rehabil.17(3), 547–579 (2007).
  • Chen H, Blanc PD, Hayden ML et al. Assessing productivity loss and activity impairment in severe or difficult to treat asthma. Value Health11, 231–239 (2008).
  • Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J. Clin. Epidemiol.45, 461–472 (1992).
  • Marks GB, Dunn SM, Woolcock AJ. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J. Clin. Epidemiol.46, 1103–1111 (1993).
  • Meads DM, McKenna SP, Doward LC et al. Development and validation of the Asthma Life Impact Scale (ALIS). Respir. Med.104, 633–643 (2010).
  • Turner-Bowker DM, Saris-Baglama RN, DeRosa MA, Paulsen CA. Development of a dynamic assessment for asthma impact: incorporating consumer and asthma specialist feedback. Ann. Behav. Med.37(Suppl. B-141) (2009).
  • Kaplan RM, Sieber WJ, Ganiats TG. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol. Health12, 783–791 (1997).
  • Feeny D, Furlong W, Torrance GW et al. Multi-attribute and single attribute utility functions for the Health Utilities Index Mark 3 System. Med. Care40, 113–128 (2002).
  • Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. Kluwer Academic Publishers, Dordrecht, The Netherlands (2003).
  • Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med. Care42, 851–859 (2004).
  • Kaplan RM, Tally S, Hays RD et al. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J. Clin. Epidemiol.64, 497–506 (2010).
  • Institute of Medicine (IOM). Valuing Health for Regulatory Cost–Effectiveness Analysis. Miller W, Robinson LA, Lawrence RS (Eds). Committee to evaluate measures of health benefits for environmental, health and safety regulation. National Academy Press, Washington, DC, USA (2006).
  • Jenkins CR, Thien FCK, Wheatley JR, Reddel HK. Traditional and patient-centred outcomes with three classes of asthma medication. Eur. Respir. J.26, 36–44 (2005).
  • Osborne ML, Pedula KL, O’Hollaren M et al. Assessing future need for acute care in adult asthmatics: the profile of asthma risk study: a prospective health maintenance organization-based study. Chest132, 1151–1161 (2007).
  • Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest108, 10–15 (1995).
  • Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. CAMP Research Group. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics118, E347–E355 (2006).
  • Szefler SJ, Martin RJ, King TS et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol.109, 410–418 (2002).
  • Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol.103, 232–237 (1999).
  • Jenkins CR, Thien FCK, Wheatley JR, Reddel HK. Traditional and patient-centred outcomes with three classes of asthma medication. Eur. Respir. J.26, 36–44 (2005).
  • Schatz M, Mosen D, Apter AJ et al. Relationships among quality of life, severity and control measures in asthma: an evaluation using factor analysis. J. Allergy Clin. Immunol.115, 1049–1055 (2005).
  • Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur. Respir. J.17, 220–224 (2001).
  • Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM. Asthma Clinical Research Network. Clinical predictors of health-related quality of life depend on asthma severity. Am. J. Respir. Crit. Care Med.163, 924–929 (2001).
  • Juniper EF, O’Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use? Respir. Med.95, 319–323 (2001).
  • Lim S, Jatakanon A, John M et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am. J. Respir. Crit. Care Med.159, 22–30 (1999).
  • Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am. J. Respir. Crit. Care Med.152, 45–52 (1995).
  • Fuhlbrigge AL. Asthma severity and asthma control: symptoms, pulmonary function and inflammatory markers. Curr. Opin. Pulm. Med.10, 1–6 (2004).
  • Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol.103, 232–237 (1999).
  • O’Byrne PM, Inman MD. Airway hyperresponsiveness. Chest123, 411S–416S (2003).
  • Leuppi JD, Salome CM, Jenkins CR et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am. J. Respir. Crit. Care Med.163, 406–412 (2001).
  • Rasmussen F, Taylor DR, Flannery EM et al. Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J. Allergy Clin. Immunol.110(2), 220–227 (2002).
  • Grol MH, Gerritsen J, Vonk JM et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study. Am. J. Respir. Crit. Care Med.160, 1830–1837 (1999).
  • O’Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline, the Normative Aging Study. Am. J. Respir. Crit. Care Med.152, 87–92 (1995).
  • Brutsche MH, Downs SH, Schindler C et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals. SAPALDIA cohort study. Thorax61, 671–677 (2006).
  • Nuijsink M, Hop WCJ, Sterk PJ, Duiverman EJ, de Jongste JC. Long-term asthma treatment guided by airway hyperresponsiveness in children, a randomised controlled trial. Eur. Respir.30, 457–466 (2007).
  • Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. The AMPUL Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsivenessas an additional guide to long-termtreatment. Am. J. Respir. Crit. Care Med.159, 1043–1051 (1999).
  • Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. Am. J. Respir. Crit. Care Med.173, 965–969 (2006).
  • Osborne ML, Pedula KL, O’Hollaren M et al. Assessing future need for acute care in adult asthmatics, the profile of asthma risk (PAR) study. A prospective health maintenance organization-based study. Chest132, 1151–1161 (2007).
  • Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts, a randomized controlled trial. Lancet360, 1715–1721 (2002).
  • Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med.352, 2163–2173 (2005).
  • Lahdensuo A, Haahtela T, Herrala J et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ312, 748–752 (1996).
  • Gibson PG, Powell H, Coughlan J et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst. Rev.1, CD001117 (2003).
  • Mancuso CA, Sayles W, Allegrante JP. Development and testing of the Asthma self-management questionnaire. Ann. Allergy Asthma Immunol.102, 294–302 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.